|By Marketwired .||
|February 1, 2013 09:00 AM EST||
CAMBRIDGE, MA -- (Marketwire) -- 02/01/13 -- Relay Technology Management Inc. is pleased to announce that a series of six articles featuring Relay Innovation Engine-powered interactive dashboards will be published open-access in Nature Reviews Drug Discovery. The first article, which was published this morning, features Relay's Epigenetics Drug Target Explorer interactive dashboard. Its publication marks the start of a new era in interactive scientific research exploration, offering readers of Nature's prestigious articles a new way to interact with the information in real-time. The article can be found here.
"We are thrilled to offer Nature the use of our interactive dashboard technology in this series of articles," says David Greenwald, Managing Director of Relay Technology Management. "This interactive dashboard in particular has tremendous value to drug development firms evaluating opportunities in the epigenetics space. Specifically, this interactive dashboard can be used by both Research & Development and Business Development groups to explore potential epigenetic targets of interest."
Relay Technology Management's Epigenetics Drug Target Explorer, the dashboard highlighted in Nature's February 1 article, is an interactive dashboard powered by the Relay Innovation Engine software platform. The analysis is based on several key translational metrics compiled over the last ten years: the degree to which epigenetic targets are emerging or established, and discussed in the scientific literature within a therapeutic targeting context. These analyses and their supporting data are visualized using Relay Technology Management's Interactive Dashboard technology.
Relay Technology Management is a strategic partner of Nature Publishing Group. Relay's flagship software-as-a-service, Business Development Live!, offers subscription-based access to interactive dashboards such as the epigenetics explorer, as well as the ability to search in real-time for the latest information on drugs, diseases, companies and targets.
About Relay Technology Management
Relay Technology Management (http://www.relaytm.com) is a life sciences business intelligence and asset comparison software provider. The Relay Innovation Engine, the software platform which powers BD Live!, supports business development and corporate strategy professionals in the life sciences industry by confirming the attractiveness of assets under consideration and unearthing new technologies. Relay aims to increase the efficiency of drug development by offering a transparent, objective and scalable approach to business intelligence and analytics.
About Nature Publishing Group
Nature Publishing Group (NPG) is a publisher of high impact scientific and medical information in print and online. NPG publishes journals, online databases, and services across the life, physical, chemical and applied sciences and clinical medicine.
Relay Technology Management, Inc.
Email: Email Contact